FDA Adverse Event Malfunction Summary report: N

INRATIO PT/INR TEST STRIPS

MDR report key: 5746536 · Received June 23, 2016

Report

Report Number
2027969-2016-00469
Event Type
Malfunction
Date Received
June 23, 2016
Date of Event
May 4, 2016
Report Date
June 6, 2016
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
GJS
PMA / PMN Number
K110212
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT IS INDICATED THAT THE PRODUCT IS NOT RETURNING FOR EVALUATION. THEREFORE, A REVIEW OF IN-HOUSE TESTING WAS PERFORMED. IN-HOUSE STRIP TESTING ON STRIP LOT K380861 MEETS CRITERIA. THE PRODUCT PERFORMED AS EXPECTED. A REVIEW OF THE MANUFACTURING RECORDS FOR THE LOT WAS PERFORMED; THE LOT MET RELEASE SPECIFICATION. UNABLE TO DETERMINE THE ROOT CAUSE OF THE CUSTOMER'S COMPLAINT. BASED ON THE INFORMATION AVAILABLE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. NO CORRECTIVE ACTION IS REQUIRED AT THIS TIME.

Additional Manufacturer Narrative · 1

THE CUSTOMER DID NOT PROVIDE A LOT NUMBER OR RETURN ANY PRODUCTS FOR INVESTIGATION. SINCE THE PRODUCT(S) ASSOCIATED WITH THE COMPLAINT WAS NOT RETURNED AND A LOT NUMBER WAS NOT PROVIDED, MANUFACTURING RECORD REVIEW COULD NOT BE PERFORMED AND FURTHER INVESTIGATION WAS NOT POSSIBLE.

Additional Manufacturer Narrative · 1

THE LOT NUMBER K380861 WAS NOT INCLUDED IN FOLLOW UP #1 ALTHOUGH THIS INFORMATION WAS PROVIDED PRIOR TO THE FOLLOW UP BEING SUBMITTED. HOWEVER, THE INFORMATION DOES INCLUDE THE INVESTIGATION PERFORMED FOR THIS LOT.

Description of Event or Problem · 1

A CALLER REPORTED A VARIANCE BETWEEN THE INRATIO INR RESULT AND ALTERNATE POC INR RESULT. THE RESULTS WERE AS FOLLOWS: (B)(6) 2016: INRATIO INR=2.7, (B)(6) 2016: ALTERNATE POC INR=1.8. THE REPORTED THERAPEUTIC RANGE IS: 2.0-2.5.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
400862 INRATIO PT/INR TEST STRIPS PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC. HS99007G1 K380861

Patients

Seq Age Sex Outcome Treatment
1